GSK closes HGSI deal

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) completed its acquisition of Human Genome Sciences Inc. (Rockville, Md.) for $14.25 per share in cash, or about $2.9 billion. The price is less than the total m...